Home
Quanex Building Products
Quanex Building Products Announces Third Quarter 2025 Results
Business
Sep 4 2025
22 min read

Quanex Building Products Announces Third Quarter 2025 Results

news images

New Segment Reporting Implemented
Balance Sheet Further Strengthened with $51.25 Million of Debt Repaid in 3Q25
Cost Synergy Target Reaffirmed
Full Year Guidance Updated

HOUSTON, Sept. 04, 2025 (GLOBE NEWSWIRE) -- Quanex Building Products Corporation (NYSE:NX) (“Quanex” or the “Company”) today announced its results for the three months ended July 31, 2025.

The Company reported the following selected financial results:

 

Three Months Ended July 31,

 

Nine Months Ended July 31,

($ in millions, except per share data)

2025

 

2024

 

2025

 

2024

Net Sales

$495.3

 

$280.3

 

$1,347.8

 

$785.7

Gross Margin

$138.0

 

$70.9

 

$361.7

 

$188.6

Gross Margin %

27.9%

 

25.3%

 

26.8%

 

24.0%

Net (loss) income

($276.0)

 

$25.4

 

($270.4)

 

$47.0

Diluted EPS

($6.04)

 

$0.77

 

($5.83)

 

$1.42

 

 

 

 

 

 

 

 

Adjusted Net Income

$31.6

 

$26.9

 

$68.4

 

$60.7

Adjusted Diluted EPS

$0.69

 

$0.81

 

$1.47

 

$1.84

Adjusted EBITDA

$70.3

 

$42.0

 

$172.0

 

$101.3

Adjusted EBITDA Margin %

14.2%

 

15.0%

 

12.8%

 

12.9%

 

 

 

 

 

 

 

 

Cash Provided by Operating Activities

$60.7

 

$46.4

 

$76.6

 

$83.3

Free Cash Flow

$46.2

 

$40.1

 

$35.6

 

$59.9

 

 

 

 

 

 

 

 

(See Non-GAAP Terminology Definitions and Disclaimers section, Non-GAAP Financial Measure Disclosure table, Selected Segment Data table and reconciliation tables for additional information)

George Wilson, Chairman, President and Chief Executive Officer, stated, “A significant amount of work had to be done to re-segment the business, so we are pleased that the work is now complete, and we are operating and reporting in our new segments. We are encouraged by the overall resilience of the business in the current environment, demonstrated by our strong cash flow, which enabled us to repay over $51 million in bank debt in the third quarter of 2025. Our balance sheet is healthy, and our liquidity improved meaningfully during the quarter. We continue to make substantial progress on the integration of the Tyman business. After identifying additional target synergies and adjusting for lower expected volumes and pushing out the timing of when we expect to realize procurement savings, we still believe there is a path to realizing approximately $45 million in cost synergies over time, which is above our initial projection of $30 million. Although macroeconomic uncertainty and low consumer confidence, as well as operational issues related to the legacy Tyman window and door hardware business in Mexico that are ongoing but temporary in nature, posed challenges for us in our third quarter, we remain optimistic about our prospects for profitable growth and value creation.

Looking ahead, we believe Quanex is well positioned due to our solid, flexible financial foundation and advantaged strategic positioning. Despite the macroeconomic uncertainty, our near-term priorities remain unchanged, which include staying focused on the Tyman integration, capturing synergies, generating cash flow to pay down debt and opportunistically repurchasing our stock. As macroeconomic uncertainty subsides and consumer confidence improves, our team is well positioned to capitalize on pent-up demand.”

Third Quarter Results Summary

Quanex generated net sales of $495.3 million during the three months ended July 31, 2025, which represents an increase of 76.7% compared to $280.3 million for the same period of 2024. The increase reflects the contribution from the Tyman acquisition that closed on August 1, 2024. Excluding the contribution from Tyman, net sales would have increased by 1.4% for the third quarter of 2025, mainly due to increased pricing and tariff passthroughs, offset by lower volumes. Inclusive of contributions from the Tyman acquisition, the Company reported increases in net sales of 201.0%, 29.6% and 40.7% for the third quarter of 2025 in its Hardware Solutions, Extruded Solutions and Custom Solutions segments, respectively.   (See Sales Analysis table for additional information)

On a consolidated basis, the decrease in reported earnings for the three months ended July 31, 2025, was primarily the result of a $302.3 million non-cash goodwill impairment related to the re-segmentation of the business. The re-segmentation occurred at a point in time when consumer confidence is low, and equity values for building products companies are depressed. The non-cash goodwill impairment is not related to any performance indicators or revisions to long-term expectations. In addition, ongoing macroeconomic uncertainty, low consumer confidence and operational challenges related to the legacy Tyman window and door hardware business in Mexico impacted results more than expected during the third quarter of 2025. The seasonal uptick Quanex started to see in the second quarter of 2025 didn’t continue to materialize to the degree the Company anticipated, and procurement related cost synergies were lower than expected.

The increase in adjusted earnings during the third quarter of 2025, compared to the same period of 2024, was mostly due to the contribution from the Tyman acquisition combined with the realization of related cost synergies.

Balance Sheet & Liquidity Update

As of July 31, 2025, the Company had total debt of $733.7 million and Quanex’s leverage ratio of Net Debt to LTM Adjusted EBITDA decreased to 2.6x. As of July 31, 2025, the Company reported a LTM Net Loss of $284.3 million, mainly due to the non-cash goodwill impairment and LTM Adjusted EBITDA was $251.8 million (See Non-GAAP Terminology Definitions and Disclaimers section, Net Debt Reconciliation table and Last Twelve Months Adjusted EBITDA Reconciliation table for additional information)

The leverage ratio for Quanex’s quarterly debt covenant compliance (“Debt Covenant Leverage Ratio”) for its lenders was 2.4x as of July 31, 2025. The Debt Covenant Leverage Ratio calculation is defined in the Company’s Amendment No. 1 to its Second Amended and Restated Credit Agreement (“Credit Agreement”), which was filed with the SEC on June 12, 2024. In general, the main difference is that the Debt Covenant Leverage Ratio excludes real-estate leases that are considered “finance” leases under U.S. GAAP and is calculated on a proforma basis to include Adjusted EBITDA from the Tyman acquisition, $30 million of EBITDA for the synergy target related to the acquisition, less realized synergies, and only cash from domestic subsidiaries. Note that per the terms of the Credit Agreement, the quarterly Debt Covenant Leverage Ratio must be less than 3.75x through the fourth quarter of 2025 and less than 3.25x starting in the first fiscal quarter of 2026. The Debt Covenant Leverage Ratio would be 2.3x if calculated using the full $66.3 million cash and cash equivalents balance as of July 31, 2025, and adjusting for the $2.1 million in cash used to repurchase stock during the quarter.

Quanex’s liquidity improved to $337.7 million as of July 31, 2025, consisting of $66.3 million in cash on hand plus availability under its Senior Secured Revolving Credit Facility due 2029, less letters of credit outstanding.

Share Repurchases

Quanex’s Board authorized a $75 million share repurchase program in December of 2021. Repurchases under this program will be made in open market transactions or privately negotiated transactions, subject to market conditions, applicable legal requirements, and other relevant factors. The Company repurchased 100,000 shares of common stock for approximately $2.1 million at an average price of $20.54 per share during the three months ended July 31, 2025. As of July 31, 2025, approximately $33.6 million remained under the existing share repurchase authorization.

Outlook

Quanex is updating its guidance for fiscal 2025 based on year-to-date results, recent demand trends, an updated cost synergy realization tracking and timing model, conversations with its customers, and a realistic timeline to address operational issues in the window and door hardware business in Mexico. On a consolidated basis for fiscal 2025, the Company now estimates that it will generate net sales of approximately $1.82 billion, which Quanex expects will yield Adjusted EBITDA* of approximately $235 million.

Mr. Wilson commented, “We have a strong team with a proven track record and a breadth of products that are unmatched in the industry, which gives us confidence in our ability to execute on our long-term operational and financial objectives.”

*When Quanex provides expectations for Adjusted EBITDA on a forward-looking basis, a reconciliation of the differences between the non-GAAP expectations and corresponding GAAP measures is generally not available without unreasonable effort. Certain items required for such a reconciliation are outside of the Company’s control and/or cannot be reasonably predicted or estimated, such as the provision for income taxes related to net income.

Conference Call and Webcast Information

The Company has also scheduled a conference call for Friday, September 5, 2025 at 11:00 a.m. ET (10:00 a.m. CT) to discuss the release. A link to the live audio webcast will be available on Quanex’s website at http://www.quanex.com in the Investors section under Presentations & Events.

Participants can pre-register for the conference call using the following link:
https://register-conf.media-server.com/register/BI1e90103192034399a255d44d3a7eb162

Registered participants will receive an email containing conference call details for dial-in options. To avoid delays, it is recommended that participants dial into the conference call ten minutes ahead of the scheduled start time. A replay will be available for a limited time on the Company’s website at http://www.quanex.com in the Investors section under Presentations & Events.

About Quanex

Quanex is a global manufacturer with core capabilities and broad applications across various end markets. The Company currently collaborates and partners with leading OEMs to provide innovative solutions in the window, door, solar, refrigeration, custom mixing, building access and cabinetry markets.  Looking ahead, Quanex plans to leverage its material science expertise and process engineering to expand into adjacent markets.

Non-GAAP Terminology Definitions and Disclaimers

Adjusted Net Income (defined as net income further adjusted to exclude amortization of step-up for purchase price adjustments on inventory, asset impairment charges, transaction, advisory fees and reorganization costs, restructuring charges related to severance and disposal of software, amortization expense related to intangible assets, pension settlement refund and other net adjustments related to foreign currency transaction gain/loss and effective tax rates reflecting impacts of adjustments on a with and without basis) and Adjusted EPS are non-GAAP financial measures that Quanex believes provide a consistent basis for comparison between periods and more accurately reflects operational performance, as they are not influenced by certain income or expense items not affecting ongoing operations. EBITDA (defined as net income or loss before interest, taxes, depreciation and amortization and other, net), Adjusted EBITDA and LTM Adjusted EBITDA (defined as EBITDA further adjusted to exclude purchase price accounting inventory step-ups, transaction costs, certain severance charges, gain/loss on the sale of certain fixed assets, restructuring charges and asset impairment charges) are non-GAAP financial measures that the Company uses to measure operational performance and assist with financial decision-making.  Net Debt is defined as total debt (outstanding balance on the revolving credit facility plus financial lease obligations) less cash and cash equivalents. The leverage ratio of Net Debt to LTM Adjusted EBITDA is a financial measure that the Company believes is useful to investors and financial analysts in evaluating Quanex’s leverage. In addition, with certain limited adjustments, this leverage ratio is the basis for a key covenant in the Company’s credit agreement.

Free Cash Flow is a non-GAAP measure calculated using cash provided by operating activities less capital expenditures. Quanex uses the Free Cash Flow metric to measure operational and cash management performance and assist with financial decision-making.   Free Cash Flow is measured before application of certain contractual commitments (including capital lease obligations), and accordingly is not a true measure of the Company’s residual cash flow available for discretionary expenditures. Quanex believes Free Cash Flow is useful to investors in understanding and evaluating the Company’s financial and cash management performance.

Quanex believes that the presented non-GAAP measures provide a consistent basis for comparison between periods and will assist investors in understanding the Company’s financial performance when comparing results to other investment opportunities.  The presented non-GAAP measures may not be the same as those used by other companies. Quanex does not intend for this information to be considered in isolation or as a substitute for other measures prepared in accordance with U.S. GAAP.

Forward Looking Statements

Statements that use the words “estimated,” “expect,” “could,” “should,” “believe,” “will,” “might,” or similar words reflecting future expectations or beliefs are forward-looking statements. The forward-looking statements include, but are not limited to, the following: impacts from public health issues (including pandemics) on the economy and the demand for Quanex’s products, timing estimates or any other expectations related to the acquisition of Tyman, the Company’s future operating results, future financial condition, future uses of cash and other expenditures, expenses and tax rates, expectations relating to Quanex’s industry, and the Company’s future growth, including any guidance discussed in this press release. The statements and guidance set forth in this release are based on current expectations. Actual results or events may differ materially from this release. For a complete discussion of factors that may affect Quanex’s future performance, please refer to the Company’s Annual Report on Form 10-K for the fiscal year ended October 31, 2024, and the Company’s Quarterly Reports on Form 10-Q under the sections entitled “Cautionary Note Regarding Forward-Looking Statements” and “Risk Factors”. Any forward-looking statements in this press release are made as of the date hereof, and Quanex undertakes no obligation to update or revise any forward-looking statements to reflect new information or events.

 

CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except per share data)
(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended July 31,

 

Nine Months Ended July 31,

 

 

2025

 

2024

 

2025

 

2024

 

 

 

 

 

 

 

 

 

Net sales

 

$

495,273

 

 

$

280,345

 

 

$

1,347,795

 

 

$

785,701

 

Cost of sales

 

 

357,305

 

 

 

209,441

 

 

 

986,129

 

 

 

597,127

 

Selling, general and administrative

 

 

71,270

 

 

 

36,509

 

 

 

208,253

 

 

 

103,579

 

Restructuring charges

 

 

1,367

 

 

 

-

 

 

 

10,207

 

 

 

-

 

Depreciation and amortization

 

 

33,882

 

 

 

10,953

 

 

 

77,814

 

 

 

32,999

 

Asset impairment charges

 

 

302,284

 

 

 

-

 

 

 

302,284

 

 

 

-

 

Operating (loss) income

 

 

(270,835

)

 

 

23,442

 

 

 

(236,892

)

 

 

51,996

 

Interest expense

 

 

(14,218

)

 

 

(878

)

 

 

(42,344

)

 

 

(2,896

)

Other, net

 

 

855

 

 

 

9,474

 

 

 

1,925

 

 

 

10,520

 

(Loss) income before income taxes

 

 

(284,198

)

 

 

32,038

 

 

 

(277,311

)

 

 

59,620

 

Income tax benefit (expense)

 

 

8,191

 

 

 

(6,688

)

 

 

6,934

 

 

 

(12,644

)

Net (loss) income

 

$

(276,007

)

 

$

25,350

 

 

$

(270,377

)

 

$

46,976

 

 

 

 

 

 

 

 

 

 

(Loss) earnings per common share, basic

 

$

(6.04

)

 

$

0.77

 

 

$

(5.83

)

 

$

1.43

 

(Loss) earnings per common share, diluted

 

$

(6.04

)

 

$

0.77

 

 

$

(5.83

)

 

$

1.42

 

 

 

 

 

 

 

 

 

 

Weighted average common shares outstanding:

 

 

 

 

 

 

 

Basic

 

 

45,691

 

 

 

32,876

 

 

 

46,395

 

 

 

32,857

 

Diluted

 

 

45,691

 

 

 

33,106

 

 

 

46,395

 

 

 

33,087

 

 

 

 

 

 

 

 

 

 

Cash dividends per share

 

$

0.08

 

 

$

0.08

 

 

$

0.24

 

 

$

0.24

 

 

 

 

 

 

 

 

 

 


 

QUANEX BUILDING PRODUCTS CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
(Unaudited)

 

 

 

 

 

 

 

July 31, 2025

 

October 31, 2024

ASSETS

 

 

 

 

Current assets:

 

 

 

 

Cash and cash equivalents

 

$

66,272

 

 

$

97,744

 

Restricted Cash

 

 

1,654

 

 

 

5,251

 

Accounts receivable, net

 

 

201,837

 

 

 

197,689

 

Inventories

 

 

272,222

 

 

 

275,550

 

Income taxes receivable

 

 

-

 

 

 

5,937

 

Prepaid and other current assets

 

 

41,339

 

 

 

29,097

 

Total current assets

 

 

583,324

 

 

 

611,268

 

Property, plant and equipment, net

 

 

405,510

 

 

 

402,466

 

Operating lease right-of-use assets

 

 

147,829

 

 

 

126,715

 

Deferred tax assets

 

 

3,654

 

 

 

3,845

 

Goodwill

 

 

271,459

 

 

 

574,711

 

Intangible assets, net

 

 

558,768

 

 

 

597,909

 

Other assets

 

 

2,133

 

 

 

2,874

 

Total assets

 

$

1,972,677

 

 

$

2,319,788

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS' EQUITY

 

 

 

 

Current liabilities:

 

 

 

 

Accounts payable

 

$

126,486

 

 

$

124,404

 

Accrued liabilities

 

 

95,378

 

 

 

103,623

 

Income taxes payable

 

 

1,273

 

 

 

6,620

 

Current maturities of long-term debt

 

 

26,313

 

 

 

25,745

 

Current operating lease liabilities

 

 

15,243

 

 

 

12,475

 

Total current liabilities

 

 

264,693

 

 

 

272,867

 

Long-term debt

 

 

695,605

 

 

 

737,198

 

Noncurrent operating lease liabilities

 

 

138,246

 

 

 

117,560

 

Deferred income taxes

 

 

143,576

 

 

 

162,304

 

Other liabilities

 

 

13,166

 

 

 

19,113

 

Total liabilities

 

 

1,255,286

 

 

 

1,309,042

 

Stockholders’ equity:

 

 

 

 

Common stock

 

 

512

 

 

 

513

 

Additional paid-in-capital

 

 

699,106

 

 

 

701,008

 

Retained earnings

 

 

148,795

 

 

 

430,405

 

Accumulated other comprehensive loss

 

 

(30,501

)

 

 

(46,428

)

Treasury stock at cost

 

 

(100,521

)

 

 

(74,752

)

Total stockholders’ equity

 

 

717,391

 

 

 

1,010,746

 

Total liabilities and stockholders' equity

 

$

1,972,677

 

 

$

2,319,788

 

 

 

 

 

 


 

QUANEX BUILDING PRODUCTS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW
(In thousands)
(Unaudited)

 

 

 

 

 

Nine Months Ended July 31,

 

2025

 

2024

Operating activities:

 

 

 

Net (loss) income

$

(270,377

)

 

$

46,976

 

Adjustments to reconcile net (loss) income to cash provided by operating activities:

 

 

 

Depreciation and amortization

 

77,814

 

 

 

32,999

 

Stock-based compensation

 

2,762

 

 

 

2,159

 

Deferred income tax

 

(26,440

)

 

 

(2,321

)

Asset impairment charge

 

302,284

 

 

 

-

 

Gain on deal contingent foreign exchange forward currency contract

 

-

 

 

 

(9,200

)

Other, net

 

9,203

 

 

 

886

 

Changes in assets and liabilities:

 

 

 

(Increase) decrease in accounts receivable

 

(1,727

)

 

 

11,114

 

Decrease (increase) in inventory

 

5,261

 

 

 

(183

)

(Increase) decrease in other current assets

 

(7,228

)

 

 

1,646

 

Increase (decrease) in accounts payable

 

144

 

 

 

(9,634

)

(Decrease) increase in accrued liabilities

 

(9,725

)

 

 

948

 

(Decrease) increase in income taxes payable

 

(21

)

 

 

6,659

 

(Decrease) increase in other long-term liabilities

 

(5,395

)

 

 

707

 

Other, net

 

88

 

 

 

577

 

Cash provided by operating activities

 

76,643

 

 

 

83,333

 

Investing activities:

 

 

 

Capital expenditures

 

(40,996

)

 

 

(23,435

)

Proceeds from disposition of capital assets

 

361

 

 

 

115

 

Cash used for investing activities

 

(40,635

)

 

 

(23,320

)

Financing activities:

 

 

 

Borrowings under credit facilities

 

170,000

 

 

 

-

 

Repayments of credit facility borrowings

 

(213,750

)

 

 

(15,000

)

Repayments of other long-term debt

 

(1,962

)

 

 

(1,893

)

Common stock dividends paid

 

(11,233

)

 

 

(7,943

)

Issuance of common stock

 

214

 

 

 

573

 

Payroll tax paid to settle shares forfeited upon vesting of stock

 

(1,400

)

 

 

(1,193

)

Purchase of treasury stock

 

(29,248

)

 

 

-

 

Cash used for financing activities

 

(87,379

)

 

 

(25,456

)

Effect of exchange rate changes on cash and cash equivalents

 

16,302

 

 

 

935

 

(Decrease) increase in cash, cash equivalents and restricted cash

 

(35,069

)

 

 

35,492

 

Cash, cash equivalents and restricted cash at beginning of period

 

102,995

 

 

 

58,474

 

Cash, cash equivalents and restricted cash at end of period

$

67,926

 

 

$

93,966

 

 

 

 

 


 

QUANEX BUILDING PRODUCTS CORPORATION
FREE CASH FLOW AND NET DEBT RECONCILIATION
(In thousands)
(Unaudited)

 

 

 

 

 

 

 

 

 

The following table reconciles the Company's calculation of Free Cash Flow, a non-GAAP measure, to its most directly comparable GAAP measure. The Company defines Free Cash Flow as cash provided by operating activities less capital expenditures.

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended July 31,

 

Nine Months Ended July 31,

 

 

2025

 

2024

 

2025

 

2024

Cash provided by operating activities

 

$60,656

 

$46,388

 

76,643

 

$83,333

Capital expenditures

 

(14,452)

 

(6,252)

 

(40,996)

 

(23,435)

Free Cash Flow

 

$46,204

 

$40,136

 

$35,647

 

$59,898

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

The following table reconciles the Company's Net Debt which is defined as total debt principal of the Company plus finance lease obligations minus cash.

 

 

 

 

 

 

 

 

 

 

 

As of July 31,

 

 

 

 

2025

 

2024

 

 

 

 

Term loan facility

 

$475,000

 

$0

 

 

 

 

Revolving credit facility

 

197,500

 

-

 

 

 

 

Finance lease obligations(1)

 

61,194

 

55,007

 

 

 

 

Total debt(2)

 

733,694

 

55,007

 

 

 

 

Less: Cash and cash equivalents

 

66,272

 

93,966

 

 

 

 

Net Debt

 

$667,422

 

($38,959)

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) Includes $58.9 million and $50.7 million in real estate lease liabilities considered finance leases under U.S. GAAP as of July 31, 2025 and 2024, respectively.

(2) Excludes outstanding letters of credit.

 

 

 

 

 

 

 

 

 


 

QUANEX BUILDING PRODUCTS CORPORATION
NON-GAAP FINANCIAL MEASURE DISCLOSURE
LAST TWELVE MONTHS ADJUSTED EBITDA RECONCILIATION
(In thousands, except per share data)
(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

Reconciliation of Last Twelve Months Adjusted EBITDA

 

Three Months Ended
July 31, 2025

 

Three Months Ended
April 30, 2025

 

Three Months Ended
January 31, 2025

 

Three Months Ended
October 31, 2024

 

Total

 

 

Reconciliation

 

Reconciliation

 

Reconciliation

 

Reconciliation

 

Reconciliation

Net (loss) income as reported

 

$

(276,007

)

 

$

20,515

 

$

(14,885

)

 

$

(13,917

)

 

$

(284,294

)

Income tax (benefit) expense

 

 

(8,191

)

 

 

6,307

 

 

(5,050

)

 

 

(3,621

)

 

 

(10,555

)

Other, net

 

 

(855

)

 

 

159

 

 

(1,229

)

 

 

2,671

 

 

 

746

 

Interest expense

 

 

14,218

 

 

 

13,940

 

 

14,186

 

 

 

17,697

 

 

 

60,041

 

Depreciation and amortization

 

 

33,882

 

 

 

19,192

 

 

24,740

 

 

 

27,329

 

 

 

105,143

 

Asset impairment charges

 

 

302,284

 

 

 

-

 

 

-

 

 

 

-

 

 

 

302,284

 

EBITDA

 

 

65,331

 

 

 

60,113

 

 

17,762

 

 

 

30,159

 

 

 

173,365

 

Cost of sales(1)

 

 

148

 

 

 

-

 

 

-

 

 

 

887

 

 

 

1,035

 

Selling, general and administrative(1),(2),(3)

 

 

3,449

 

 

 

864

 

 

12,876

 

 

 

50,004

 

 

 

67,193

 

Restructuring charges(4)

 

 

1,367

 

 

 

936

 

 

7,904

 

 

 

-

 

 

 

10,207

 

Adjusted EBITDA

 

$

70,295

 

 

$

61,913

 

$

38,542

 

 

$

81,050

 

 

$

251,800

 

 

 

 

 

 

 

 

 

 

 

 

(1) Expense related to plant closure/relocation.

(2) Transaction, advisory fees, reorganization costs and product recall expenses.

(3) Amortization of step-up for purchase price adjustments on inventory.

(4) Restructuring charges related to severeance and disposal of software.

 

 

 

 

 

 

 

 

 

 

 


 

QUANEX BUILDING PRODUCTS CORPORATION
NON-GAAP FINANCIAL MEASURE DISCLOSURE
(In thousands, except per share data)
(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reconciliation of Adjusted Net Income and Adjusted EPS

 

Three Months Ended July 31, 2025

 

Three Months Ended July 31, 2024

 

Nine Months Ended July 31, 2025

 

Nine Months Ended July 31, 2024

 

 

 

Net
Income

 

Diluted
EPS

 

Net
Income

 

Diluted
EPS

 

Net
Income

 

Diluted
EPS

 

Net
Income

 

Diluted
EPS

 

Net (loss) income as reported

 

$

(276,007

)

 

$

(6.04

)

 

$

25,350

 

 

$

0.77

 

 

$

(270,377

)

 

$

(5.83

)

 

$

46,976

 

 

$

1.42

 

 

Net (loss) income reconciling items from below

 

 

307,578

 

 

$

6.73

 

 

 

1,597

 

 

$

0.04

 

 

 

338,756

 

 

$

7.30

 

 

 

13,757

 

 

$

0.42

 

 

Adjusted net income and adjusted EPS

 

$

31,571

 

 

$

0.69

 

 

$

26,947

 

 

$

0.81

 

 

$

68,379

 

 

$

1.47

 

 

$

60,733

 

 

$

1.84

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reconciliation of Adjusted EBITDA

 

Three Months Ended July 31, 2025

 

Three Months Ended July 31, 2024

 

Nine Months Ended July 31, 2025

 

Nine Months Ended July 31, 2024

 

 

 

Reconciliation

 

 

 

Reconciliation

 

 

 

Reconciliation

 

 

 

Reconciliation

 

 

 

Net (loss) income as reported

 

$

(276,007

)

 

 

 

$

25,350

 

 

 

 

$

(270,377

)

 

 

 

$

46,976

 

 

 

 

Income tax (benefit) expense

 

 

(8,191

)

 

 

 

 

6,688

 

 

 

 

 

(6,934

)

 

 

 

 

12,644

 

 

 

 

Other, net

 

 

(855

)

 

 

 

 

(9,474

)

 

 

 

 

(1,925

)

 

 

 

 

(10,520

)

 

 

 

Interest expense

 

 

14,218

 

 

 

 

 

878

 

 

 

 

 

42,344

 

 

 

 

 

2,896

 

 

 

 

Depreciation and amortization

 

 

33,882

 

 

 

 

 

10,953

 

 

 

 

 

77,814

 

 

 

 

 

32,999

 

 

 

 

Asset impairment charges

 

 

302,284

 

 

 

 

 

-

 

 

 

 

 

302,284

 

 

 

 

 

-

 

 

 

 

EBITDA

 

 

65,331

 

 

 

 

 

34,395

 

 

 

 

 

143,206

 

 

 

 

 

84,995

 

 

 

 

EBITDA reconciling items from below

 

 

4,964

 

 

 

 

 

7,640

 

 

 

 

 

28,766

 

 

 

 

 

16,338

 

 

 

 

Adjusted EBITDA

 

$

70,295

 

 

 

 

$

42,035

 

 

 

 

$

171,972

 

 

 

 

$

101,333

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reconciling Items

 

Three Months Ended July 31, 2025

 

Three Months Ended July 31, 2024

 

Nine Months Ended July 31, 2025

 

Nine Months Ended July 31, 2024

 

 

 

Income Statement

 

Reconciling Items

 

Income Statement

 

Reconciling Items

 

Income Statement

 

Reconciling Items

 

Income Statement

 

Reconciling Items

 

Net sales

 

$

495,273

 

 

$

-

 

 

$

280,345

 

 

$

-

 

 

$

1,347,795

 

 

$

-

 

 

$

785,701

 

 

$

-

 

 

Cost of sales

 

 

357,305

 

 

 

(148

)

(1)

 

209,441

 

 

 

(1,507

)

(1)

 

986,129

 

 

 

(1,124

)

(1)

 

597,127

 

 

 

(2,138

)

(1)

Selling, general and administrative

 

 

71,270

 

 

 

(3,449

)

(1), (2)

 

36,509

 

 

 

(6,133

)

(1), (2)

 

208,253

 

 

 

(17,435

)

(1), (2), (3)

 

103,579

 

 

 

(14,200

)

(1), (2)

Restructuring charges

 

 

1,367

 

 

 

(1,367

)

(4)

 

-

 

 

 

-

 

 

 

10,207

 

 

 

(10,207

)

(4)

 

-

 

 

 

-

 

 

EBITDA

 

 

65,331

 

 

 

4,964

 

 

 

34,395

 

 

 

7,640

 

 

 

143,206

 

 

 

28,766

 

 

 

84,995

 

 

 

16,338

 

 

Asset impairment charges

 

 

302,284

 

 

 

(302,284

)

(5)

 

-

 

 

 

-

 

 

 

302,284

 

 

 

(302,284

)

(5)

 

-

 

 

 

-

 

 

Depreciation and amortization

 

 

33,882

 

 

 

(19,604

)

(6)

 

10,953

 

 

 

(2,796

)

(6)

 

77,814

 

 

 

(36,708

)

(6)

 

32,999

 

 

 

(8,982

)

(6)

Operating income

 

 

(270,835

)

 

 

326,852

 

 

 

23,442

 

 

 

10,436

 

 

 

(236,892

)

 

 

367,758

 

 

 

51,996

 

 

 

25,320

 

 

Interest expense

 

 

(14,218

)

 

 

-

 

 

 

(878

)

 

 

-

 

 

 

(42,344

)

 

 

-

 

 

 

(2,896

)

 

 

-

 

 

Other, net

 

 

855

 

 

 

(949

)

(7)

 

9,474

 

 

 

(9,162

)

(7)

 

1,925

 

 

 

(118

)

(7)

 

10,520

 

 

 

(10,009

)

(7)

Income before income taxes

 

 

(284,198

)

 

 

325,903

 

 

 

32,038

 

 

 

1,274

 

 

 

(277,311

)

 

 

367,640

 

 

 

59,620

 

 

 

15,311

 

 

Income tax expense

 

 

8,191

 

 

 

(18,325

)

(8)

 

(6,688

)

 

 

323

 

(8)

 

6,934

 

 

 

(28,884

)

(8)

 

(12,644

)

 

 

(1,554

)

(8)

Net (loss) income

 

$

(276,007

)

 

$

307,578

 

 

$

25,350

 

 

$

1,597

 

 

$

(270,377

)

 

$

338,756

 

 

$

46,976

 

 

$

13,757

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted (loss) earnings per share

 

$

(6.04

)

 

 

 

$

0.77

 

 

 

 

$

(5.83

)

 

 

 

$

1.42

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(1) Expense related to plant closure/relocation.

(2) Transaction, advisory fees, reorganization costs and product recall expenses.

(3) Amortization of step-up for purchase price adjustments on inventory.

(4) Restructuring charges related to severeance and disposal of software.

(5) Goodwill impairment.

(6) Amortization expense related to intangible assets and onetime deprecation adjustment.

(7) Pension settlement refund and foreign currency transaction gains.

(8) Tax impact of net income reconciling items.

 


 

QUANEX BUILDING PRODUCTS CORPORATION
SELECTED SEGMENT DATA
(In thousands)
(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

This table provides gross margin, operating income (loss), EBITDA, and Adjusted EBITDA by reportable segment. Non-operating expense and income tax expense are not allocated to the reportable segments.

 

 

 

 

 

 

 

 

 

 

 

 

 

Hardware Solutions

 

Extruded Solutions

 

Custom Solutions

 

Unallocated Corp & Other

 

Total

Three months ended July 31, 2025

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

227,116

 

 

$

174,427

 

 

$

102,264

 

 

$

(8,534

)

 

$

495,273

 

Cost of sales

 

 

170,282

 

 

 

116,597

 

 

 

77,755

 

 

 

(7,329

)

 

 

357,305

 

Gross Margin

 

 

56,834

 

 

 

57,830

 

 

 

24,509

 

 

 

(1,205

)

 

 

137,968

 

Gross Margin %

 

 

25.0%

 

 

 

33.2%

 

 

 

24.0%

 

 

 

 

 

27.9%

 

Selling, general and administrative(1)

 

 

32,954

 

 

 

20,740

 

 

 

11,708

 

 

 

5,868

 

 

 

71,270

 

Restructuring charges

 

 

1,140

 

 

 

34

 

 

 

26

 

 

 

167

 

 

 

1,367

 

Depreciation and amortization

 

 

16,987

 

 

 

6,989

 

 

 

4,716

 

 

 

5,190

 

 

 

33,882

 

Asset impairment charges

 

 

163,198

 

 

 

54,934

 

 

 

84,152

 

 

 

-

 

 

 

302,284

 

Operating loss

 

 

(157,445

)

 

 

(24,867

)

 

 

(76,093

)

 

 

(12,430

)

 

 

(270,835

)

Depreciation and amortization

 

 

16,987

 

 

 

6,989

 

 

 

4,716

 

 

 

5,190

 

 

 

33,882

 

Asset impairment charges

 

 

163,198

 

 

 

54,934

 

 

 

84,152

 

 

 

-

 

 

 

302,284

 

EBITDA

 

 

22,740

 

 

 

37,056

 

 

 

12,775

 

 

&nbs...p;

(7,240

)

 

 

65,331

 

Expense related to plant relocation (Cost of sales)

 

 

148

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

148

 

Transaction, advisory fees, reorganization costs, and product recall expenses

 

 

715

 

 

 

-

 

 

 

50

 

 

 

2,684

 

 

 

3,449

 

Restructuring charges related to severance

 

 

1,140

 

 

 

34

 

 

 

26

 

 

 

167

 

 

 

1,367

 

Adjusted EBITDA

 

$

24,743

 

 

$

37,090

 

 

$

12,851

 

 

$

(4,389

)

 

$

70,295

 

Adjusted EBITDA Margin %

 

 

10.9%

 

 

 

21.3%

 

 

 

12.6%

 

 

 

 

 

14.2%

 

 

 

 

 

 

 

 

 

 

 

 

Three months ended July 31, 2024

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

75,460

 

 

$

134,552

 

 

$

72,667

 

 

$

(2,334

)

 

$

280,345

 

Cost of sales

 

 

59,092

 

 

 

92,790

 

 

 

59,973

 

 

 

(2,414

)

 

 

209,441

 

Gross Margin

 

 

16,368

 

 

 

41,762

 

 

 

12,694

 

 

 

80

 

 

 

70,904

 

Gross Margin %

 

 

21.7%

 

 

 

31.0%

 

 

 

17.5%

 

 

 

 

 

25.3%

 

Selling, general and administrative(1)

 

 

6,906

 

 

 

15,648

 

 

 

6,559

 

 

 

7,396

 

 

 

36,509

 

Depreciation and amortization

 

 

1,225

 

 

 

5,460

 

 

 

4,211

 

 

 

57

 

 

 

10,953

 

Operating income (loss)

 

 

8,237

 

 

 

20,654

 

 

 

1,924

 

 

 

(7,373

)

 

 

23,442

 

Depreciation and amortization

 

 

1,225

 

 

 

5,460

 

 

 

4,211

 

 

 

57

 

 

 

10,953

 

EBITDA

 

 

9,462

 

 

 

26,114

 

 

 

6,135

 

 

 

(7,316

)

 

 

34,395

 

Expense related to plant closure (Cost of sales)

 

 

-

 

 

 

1,507

 

 

 

-

 

 

 

-

 

 

 

1,507

 

Expense related to plant closure (SG&A)

 

 

-

 

 

 

125

 

 

 

-

 

 

 

-

 

 

 

125

 

Transaction and advisory fees

 

 

-

 

 

 

-

 

 

 

-

 

 

 

6,008

 

 

 

6,008

 

Adjusted EBITDA

 

$

9,462

 

 

$

27,746

 

 

$

6,135

 

 

$

(1,308

)

 

$

42,035

 

Adjusted EBITDA Margin %

 

 

12.5%

 

 

 

20.6%

 

 

 

8.4%

 

 

 

 

 

15.0%

 

 

 

 

 

 

 

 

 

 

 

 

Nine months ended July 31, 2025

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

614,791

 

 

$

478,024

 

 

$

284,809

 

 

$

(29,829

)

 

$

1,347,795

 

Cost of sales

 

 

466,600

 

 

 

325,914

 

 

 

219,755

 

 

 

(26,140

)

 

 

986,129

 

Gross Margin

 

 

148,191

 

 

 

152,110

 

 

 

65,054

 

 

 

(3,689

)

 

 

361,666

 

Gross Margin %

 

 

24.1%

 

 

 

31.8%

 

 

 

22.8%

 

 

 

 

 

26.8%

 

Selling, general and administrative(1)

 

 

98,570

 

 

 

60,921

 

 

 

34,156

 

 

 

14,606

 

 

 

208,253

 

Restructuring charges

 

 

8,155

 

 

 

34

 

 

 

26

 

 

 

1,992

 

 

 

10,207

 

Depreciation and amortization

 

 

38,818

 

 

 

22,066

 

 

 

15,693

 

 

 

1,237

 

 

 

77,814

 

Asset impairment charges

 

 

163,198

 

 

 

54,934

 

 

 

84,152

 

 

 

-

 

 

 

302,284

 

Operating (loss) income

 

 

(160,550

)

 

 

14,155

 

 

 

(68,973

)

 

 

(21,524

)

 

 

(236,892

)

Depreciation and amortization

 

 

38,818

 

 

 

22,066

 

 

 

15,693

 

 

 

1,237

 

 

 

77,814

 

Asset impairment charges

 

 

163,198

 

 

 

54,934

 

 

 

84,152

 

 

 

-

 

 

 

302,284

 

EBITDA

 

 

41,466

 

 

 

91,155

 

 

 

30,872

 

 

 

(20,287

)

 

 

143,206

 

Expense related to plant relocation (Cost of sales)

 

 

1,124

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,124

 

Expense related to plant relocation (SG&A)

 

 

247

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

247

 

Amortization of step-up for purchase price adjustments on inventory.

 

 

7,276

 

 

 

1,428

 

 

 

302

 

 

 

-

 

 

 

9,006

 

Transaction, advisory fees, reorganization costs, and product recall expenses

 

 

1,397

 

 

 

177

 

 

 

50

 

 

 

6,558

 

 

 

8,182

 

Restructuring charges related to severance and disposal of software

 

 

8,155

 

 

 

34

 

 

 

26

 

 

 

1,992

 

 

 

10,207

 

Adjusted EBITDA

 

$

59,665

 

 

$

92,794

 

 

$

31,250

 

 

$

(11,737

)

 

$

171,972

 

Adjusted EBITDA Margin %

 

 

9.7%

 

 

 

19.4%

 

 

 

11.0%

 

 

 

 

 

12.8%

 

 

 

 

 

 

 

 

 

 

 

 

Nine months ended July 31, 2024

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

204,127

 

 

$

379,860

 

 

$

208,201

 

 

$

(6,487

)

 

$

785,701

 

Cost of sales

 

 

165,952

 

 

 

263,107

 

 

 

174,365

 

 

 

(6,297

)

 

 

597,127

 

Gross Margin

 

 

38,175

 

 

 

116,753

 

 

 

33,836

 

 

 

(190

)

 

 

188,574

 

Gross Margin %

 

 

18.7%

 

 

 

30.7%

 

 

 

16.3%

 

 

 

 

 

24.0%

 

Selling, general and administrative(1)

 

 

18,704

 

 

 

45,733

 

 

 

19,456

 

 

 

19,686

 

 

 

103,579

 

Depreciation and amortization

 

 

3,531

 

 

 

16,616

 

 

 

12,685

 

 

 

167

 

 

 

32,999

 

Operating income (loss)

 

 

15,940

 

 

 

54,404

 

 

 

1,695

 

 

 

(20,043

)

 

 

51,996

 

Depreciation and amortization

 

 

3,531

 

 

 

16,616

 

 

 

12,685

 

 

 

167

 

 

 

32,999

 

EBITDA

 

 

19,471

 

 

 

71,020

 

 

 

14,380

 

 

 

(19,876

)

 

 

84,995

 

Expense related to plant closure (Cost of sales)

 

 

-

 

 

 

2,138

 

 

 

-

 

 

 

-

 

 

 

2,138

 

Expense related to plant closure (SG&A)

 

 

-

 

 

 

1,103

 

 

 

-

 

 

 

-

 

 

 

1,103

 

Transaction and advisory fees

 

 

-

 

 

 

-

 

 

 

-

 

 

 

13,097

 

 

 

13,097

 

Adjusted EBITDA

 

$

19,471

 

 

$

74,261

 

 

$

14,380

 

 

$

(6,779

)

 

$

101,333

 

Adjusted EBITDA Margin %

 

 

9.5%

 

 

 

19.5%

 

 

 

6.9%

 

 

 

 

 

12.9%

 

 

 

 

 

 

 

 

 

 

 

 

(1) Includes stock-based compensation expense for the three and nine months ended July 31, 2025, respectively of $1.8 million and $3.6 million, and $1.3 million and $5.3 million for the comparable prior year periods.

 

 

 

 

 

 

 

 

 

 

 


 

QUANEX BUILDING PRODUCTS CORPORATION
SELECTED SEGMENT DATA RECONCILIATION
(In thousands)
(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

This table reconciles our segment presentation, as previously reported in Exhibit 99.1 to our Current Report Form 8-K dated August 12, 2024 for the three and nine months ended July 31, 2024, to the current presentation.

 

 

 

 

 

 

 

 

 

 

 

 

 

NA Fenestration

 

EU Fenestration

 

NA Cabinet Components

 

Unallocated Corp & Other

 

Total

Three months ended July 31, 2024

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

170,258

 

 

$

59,617

 

 

$

51,448

 

 

$

(978

)

 

$

280,345

 

Cost of sales

 

 

130,301

 

 

 

36,930

 

 

 

42,911

 

 

 

(701

)

 

 

209,441

 

Gross Margin

 

 

39,957

 

 

 

22,687

 

 

 

8,537

 

 

 

(277

)

 

 

70,904

 

Gross Margin %

 

 

23.5%

 

 

 

38.1%

 

 

 

16.6%

 

 

 

 

 

25.3%

 

Selling, general and administrative

 

 

16,918

 

 

 

7,390

 

 

 

5,162

 

 

 

7,039

 

 

 

36,509

 

Depreciation and amortization

 

 

5,194

 

 

 

2,609

 

 

 

3,093

 

 

 

57

 

 

 

10,953

 

Operating income (loss)

 

 

17,845

 

 

 

12,688

 

 

 

282

 

 

 

(7,373

)

 

 

23,442

 

Depreciation and amortization

 

 

5,194

 

 

 

2,609

 

 

 

3,093

 

 

 

57

 

 

 

10,953

 

EBITDA

 

 

23,039

 

 

 

15,297

 

 

 

3,375

 

 

 

(7,316

)

 

 

34,395

 

Expense related to plant closure (Cost of sales)

 

 

1,507

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,507

 

Expense related to plant closure (SG&A)

 

 

125

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

125

 

Transaction and advisory fees

 

 

-

 

 

 

-

 

 

 

-

 

 

 

6,008

 

 

 

6,008

 

Adjusted EBITDA

 

$

24,671

 

 

$

15,297

 

 

$

3,375

 

 

$

(1,308

)

 

$

42,035

 

Adjusted EBITDA Margin %

 

 

14.5%

 

 

 

25.7%

 

 

 

6.6%

 

 

 

 

 

15.0%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Hardware Solutions(1)

 

Extruded Solutions(2)

 

Custom Solutions(3)

 

Unallocated Corp & Other

 

Total

Three months ended July 31, 2024

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

75,460

 

 

$

134,552

 

 

$

72,667

 

 

$

(2,334

)

 

$

280,345

 

Cost of sales

 

 

59,092

 

 

 

92,790

 

 

 

59,973

 

 

 

(2,414

)

 

 

209,441

 

Gross Margin

 

 

16,368

 

 

 

41,762

 

 

 

12,694

 

 

 

80

 

 

 

70,904

 

Gross Margin %

 

 

21.7%

 

 

 

31.0%

 

 

 

17.5%

 

 

 

 

 

25.3%

 

Selling, general and administrative

 

 

6,906

 

 

 

15,648

 

 

 

6,559

 

 

 

7,396

 

 

 

36,509

 

Depreciation and amortization

 

 

1,225

 

 

 

5,460

 

 

 

4,211

 

 

 

57

 

 

 

10,953

 

Operating income

 

 

8,237

 

 

 

20,654

 

 

 

1,924

 

 

 

(7,373

)

 

 

23,442

 

Depreciation and amortization

 

 

1,225

 

 

 

5,460

 

 

 

4,211

 

 

 

57

 

 

 

10,953

 

EBITDA

 

 

9,462

 

 

 

26,114

 

 

 

6,135

 

 

 

(7,316

)

 

 

34,395

 

Expense related to plant closure (Cost of sales)

 

 

-

 

 

 

1,507

 

 

 

-

 

 

 

-

 

 

 

1,507

 

Expense related to plant closure (SG&A)

 

 

-

 

 

 

125

 

 

 

-

 

 

 

-

 

 

 

125

 

Transaction and advisory fees

 

 

-

 

 

 

-

 

 

 

-

 

 

 

6,008

 

 

 

6,008

 

Adjusted EBITDA

 

$

9,462

 

 

$

27,746

 

 

$

6,135

 

 

$

(1,308

)

 

$

42,035

 

Adjusted EBITDA Margin %

 

 

12.5%

 

 

 

20.6%

 

 

 

8.4%

 

 

 

 

 

15.0%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

NA Fenestration

 

EU Fenestration

 

NA Cabinet Components

 

Unallocated Corp & Other

 

Total

Nine months ended July 31, 2024

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

478,027

 

 

$

165,637

 

 

$

145,663

 

 

$

(3,626

)

 

$

785,701

 

Cost of sales

 

 

370,930

 

 

 

104,327

 

 

 

124,278

 

 

 

(2,408

)

 

 

597,127

 

Gross Margin

 

 

107,097

 

 

 

61,310

 

 

 

21,385

 

 

 

(1,218

)

 

 

188,574

 

Gross Margin %

 

 

22.4%

 

 

 

37.0%

 

 

 

14.7%

 

 

 

 

 

24.0%

 

Selling, general and administrative

 

 

46,558

 

 

 

23,008

 

 

 

15,354

 

 

 

18,659

 

 

 

103,579

 

Depreciation and amortization

 

 

15,887

 

 

 

7,705

 

 

 

9,240

 

 

 

167

 

 

 

32,999

 

Operating income (loss)

 

 

44,652

 

 

 

30,597

 

 

 

(3,209

)

 

 

(20,044

)

 

 

51,996

 

Depreciation and amortization

 

 

15,887

 

 

 

7,705

 

 

 

9,240

 

 

 

167

 

 

 

32,999

 

EBITDA

 

 

60,539

 

 

 

38,302

 

 

 

6,031

 

 

 

(19,877

)

 

 

84,995

 

Expense related to plant closure (Cost of sales)

 

 

2,138

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

2,138

 

Expense related to plant closure (SG&A)

 

 

1,103

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

1,103

 

Transaction and advisory fees

 

 

-

 

 

 

-

 

 

 

-

 

 

 

13,097

 

 

 

13,097

 

Adjusted EBITDA

 

$

63,780

 

 

$

38,302

 

 

$

6,031

 

 

$

(6,780

)

 

$

101,333

 

Adjusted EBITDA Margin %

 

 

13.3%

 

 

 

23.1%

 

 

 

4.1%

 

 

 

 

 

12.9%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Hardware Solutions(1)

 

Extruded Solutions(2)

 

Custom Solutions(3)

 

Unallocated Corp & Other

 

Total

Nine months ended July 31, 2024

 

 

 

 

 

 

 

 

 

 

Net sales

 

$

204,127

 

 

$

379,860

 

 

$

208,201

 

 

$

(6,487

)

 

$

785,701

 

Cost of sales

 

 

165,952

 

 

 

263,107

 

 

 

174,365

 

 

 

(6,297

)

 

 

597,127

 

Gross Margin

 

 

38,175

 

 

 

116,753

 

 

 

33,836

 

 

 

(190

)

 

 

188,574

 

Gross Margin %

 

 

18.7%

 

 

 

30.7%

 

 

 

16.3%

 

 

 

 

 

24.0%

 

Selling, general and administrative

 

 

18,704

 

 

 

45,733

 

 

 

19,456

 

 

 

19,686

 

 

 

103,579

 

Depreciation and amortization

 

 

3,531

 

 

 

16,616

 

 

 

12,685

 

 

 

167

 

 

 

32,999

 

Operating income (loss)

 

 

15,940

 

 

 

54,404

 

 

 

1,695

 

 

 

(20,043

)

 

 

51,996

 

Depreciation and amortization

 

 

3,531

 

 

 

16,616

 

 

 

12,685

 

 

 

167

 

 

 

32,999

 

EBITDA

 

 

19,471

 

 

 

71,020

 

 

 

14,380

 

 

 

(19,876

)

 

 

84,995

 

Loss on damage to manufacturing facilities (Cost of sales)

 

 

-

 

 

 

2,138

 

 

 

-

 

 

 

-

 

 

 

2,138

 

Loss on damage to manufacturing facilities (SG&A)

 

 

-

 

 

 

1,103

 

 

 

-

 

 

 

-

 

 

 

1,103

 

Transaction and advisory fees

 

 

-

 

 

 

-

 

 

 

-

 

 

 

13,097

 

 

 

13,097

 

Adjusted EBITDA

 

$

19,471

 

 

$

74,261

 

 

$

14,380

 

 

$

(6,779

)

 

$

101,333

 

Adjusted EBITDA Margin %

 

 

9.5%

 

 

 

19.5%

 

 

 

6.9%

 

 

 

 

 

12.9%

 

 

 

 

 

 

 

 

 

 

 

 

(1) The Hardware Solutions segment contains a portion of the previously reported NA Fenestration segment.

(2) The Extruded Solutions segment contains a portion of the NA Fenestration segment and the EU Fenestration segment.

(3) The Custom Solutions segment contains a portion of the NA Fenestration segment and the NA Cabinet Components segment.

 

 

 

 

 

 

 

 

 

 

 


 

QUANEX BUILDING PRODUCTS CORPORATION
SALES ANALYSIS
(In thousands)
(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

Three Months Ended July 31,

 

Nine Months Ended July 31,

 

 

2025

 

2024

 

2025

 

2024

 

 

 

 

 

 

 

 

 

Hardware Solutions:

 

 

 

 

 

 

 

 

Window and door hardware

$

150,307

 

 

$

-

 

 

$

411,522

 

 

$

-

 

 

Screens

 

76,809

 

 

 

75,460

 

 

 

203,269

 

 

 

204,127

 

 

 

$

227,116

 

 

$

75,460

 

 

$

614,791

 

 

$

204,127

 

Extruded Solutions:(1)

 

 

 

 

 

 

 

 

Window profiles

$

68,165

 

 

$

67,802

 

 

$

182,273

 

 

$

193,758

 

 

Seals and gaskets

 

29,865

 

 

 

16,513

 

 

 

84,915

 

 

 

42,714

 

 

Spacers

 

54,743

 

 

 

37,868

 

 

 

146,544

 

 

 

104,047

 

 

Solar

 

5,250

 

 

 

5,198

 

 

 

17,835

 

 

 

16,074

 

 

Flashing Tape

 

3,038

 

 

 

4,905

 

 

 

6,751

 

 

 

13,512

 

 

Window and door hardware

 

10,044

 

 

 

-

 

 

 

29,694

 

 

 

-

 

 

Other

 

3,322

 

 

 

2,266

 

 

 

10,012

 

 

 

9,755

 

 

 

$

174,427

 

 

$

134,552

 

 

$

478,024

 

 

$

379,860

 

Custom Solutions:

 

 

 

 

 

 

 

 

Wood solutions

$

53,409

 

 

$

51,448

 

 

$

148,456

 

 

$

145,663

 

 

Access solutions

 

27,370

 

 

 

-

 

 

 

74,158

 

 

 

-

 

 

Mixing solutions

 

21,485

 

 

 

21,219

 

 

 

62,195

 

 

 

62,538

 

 

 

$

102,264

 

 

$

72,667

 

 

$

284,809

 

 

$

208,201

 

 

 

 

 

 

 

 

 

 

Unallocated Corporate & Other:

 

 

 

 

 

 

 

 

Eliminations

$

(8,534

)

 

$

(2,334

)

 

$

(29,829

)

 

$

(6,487

)

 

 

$

(8,534

)

 

$

(2,334

)

 

$

(29,829

)

 

$

(6,487

)

 

 

 

 

 

 

 

 

 

Net Sales

$

495,273

 

 

$

280,345

 

 

$

1,347,795

 

 

$

785,701

 

 

 

 

 

 

 

 

 

 

(1) Reflects an increase of $2.6 million and $2.9 million in revenue associated with foreign currency exchange rate impacts for the three and nine months ended July 31, 2025, respectively.

 


Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren